Cardiac MRI vs Echocardiography for Diagnosing Cardiac Amyloidosis

Initial Imaging Approach

The American Heart Association recommends echocardiography as the first-line cardiac imaging modality when cardiac amyloidosis is suspected or in patients with systemic amyloidosis and heart failure 1, 2
Echocardiography should be performed first in all suspected cases, with cardiac MRI reserved for cases where echo is suggestive or equivocal 1, 2

Diagnostic Performance of Cardiac MRI

Cardiac MRI demonstrates excellent diagnostic characteristics, with a sensitivity of 80-92% and specificity of 87-94% for detecting cardiac amyloidosis using late gadolinium enhancement (LGE) patterns 3
The hallmark finding is diffuse subendocardial LGE distributed circumferentially, which has 88% sensitivity and 100% specificity for AL amyloidosis specifically 3
Myocardial nulling before blood pool nulling on inversion recovery sequences has 71-100% sensitivity and 70-100% specificity depending on the study 3

Key MRI Features to Identify

Diffuse subendocardial or transmural LGE involvement is a key feature of cardiac amyloidosis 3
Elevated native T1 values (>1020-1044 ms depending on technique) are also indicative of cardiac amyloidosis 4
Abnormal gadolinium kinetics with difficulty nulling myocardium is another key feature 3

Important Caveats and Limitations

The 2016 AHA statement notes that the accuracy and utility of cardiac MRI for the diagnosis of cardiac amyloidosis are still uncertain, though it acknowledges MRI can help identify the extent of cardiac involvement in patients with established amyloidosis 1, 5

When MRI Adds Most Value

Cardiac MRI is particularly useful when echocardiography shows suggestive but not definitive findings of infiltrative cardiomyopathy 5
Cardiac MRI is also useful for tissue characterization to differentiate cardiac amyloidosis from other causes of LV hypertrophy (hypertrophic cardiomyopathy, hypertensive heart disease) 3
For prognostication, as LGE presence and extent predict mortality (OR 2.73-19.84 depending on pattern) 3, 4

Integration with Other Diagnostic Modalities

Nuclear imaging (99mTc-PYP/DPD/HMDP) can be diagnostic for ATTR amyloidosis without biopsy when grade 2-3 uptake is present and monoclonal protein screening is negative 1, 3, 6

Screening for Cardiac Amyloidosis

Clinical Red Flags That Should Trigger Screening

The American Heart Association recommends screening for cardiac amyloidosis when patients have LV wall thickness ≥12-14 mm with discordance between wall thickness on echo and low QRS voltage on ECG 7, 8
The American College of Cardiology suggests that heart failure with preserved ejection fraction (HFpEF) is a high-risk feature for cardiac amyloidosis 8
Bilateral carpal tunnel syndrome, especially without rheumatoid arthritis or trauma, is a clinical red flag for cardiac amyloidosis 7, 9
Lumbar spinal stenosis or prior orthopedic procedures are also clinical red flags for cardiac amyloidosis 7
Spontaneous biceps tendon rupture is a clinical red flag for cardiac amyloidosis 7, 9
Autonomic or sensory polyneuropathy (unexplained) is a clinical red flag for cardiac amyloidosis 8
Aortic stenosis with unexplained LV hypertrophy is a clinical red flag for cardiac amyloidosis 8

Step-by-Step Diagnostic Algorithm

The American Heart Association recommends starting with monoclonal protein screening, including serum and urine immunofixation electrophoresis and serum free light chain assay 8, 10
Echocardiography is the initial cardiac imaging test, with findings including LV wall thickening (>12 mm), apical sparing pattern on longitudinal strain, and grade ≥2 diastolic dysfunction 7, 9, 11
Cardiac MRI is appropriate when echo is suggestive, with findings including diffuse subendocardial or transmural late gadolinium enhancement and elevated native T1 and extracellular volume (ECV >0.40) 9, 11, 12

Additional Screening Tools

Biomarkers that support suspicion of cardiac amyloidosis include disproportionately elevated NT-proBNP relative to degree of heart failure and elevated troponin (T, I, or high-sensitivity) 7, 9
ECG findings that support suspicion of cardiac amyloidosis include low QRS voltage, pseudoinfarct pattern, and voltage-to-mass discordance 7, 10, 13

Echocardiographic Diagnostic Criteria for Cardiac Amyloidosis

Structural Abnormalities

The American College of Cardiology recommends transthoracic echocardiography as the primary diagnostic imaging tool for suspected cardiac amyloidosis, providing multiple "red flag" findings that should prompt further diagnostic workup, including increased LV wall thickness and small LV cavity size 14
Increased LV wall thickness (≥12 mm) is the hallmark structural finding, often with a small LV cavity size, according to the American Heart Association 15
Biatrial enlargement is commonly present and disproportionate to the degree of ventricular dysfunction, as noted by the European Society of Cardiology 15
Thickened cardiac valves without significant stenosis are a characteristic finding, as reported by the American College of Cardiology 15
Increased atrial septal thickness is a notable feature, according to the European Society of Cardiology 15
Pericardial effusion may be present, as indicated by the American Heart Association 15

Functional Abnormalities

Restrictive transmitral Doppler filling pattern is characteristic, reflecting severe diastolic dysfunction, as emphasized by the American College of Cardiology 15
Reduced ventricular longitudinal strain with a characteristic apical sparing pattern is a key finding, according to the European Society of Cardiology 15
Apical-to-basal strain ratio >2.1 is highly suggestive of cardiac amyloidosis, as reported by the American Heart Association 15
LV ejection fraction-to-strain ratio >4 is a notable feature, as indicated by the European Society of Cardiology 15

Diagnostic Clues and Advanced Techniques

The combination of low QRS voltage on ECG with increased LV wall thickness on echocardiography (>12 mm) is particularly useful for raising clinical suspicion of cardiac amyloidosis, as noted by the American College of Cardiology 15
Speckle-tracking analysis is recommended by multiple international guidelines (CCS/CHFS, JCS, DGK) as part of comprehensive echocardiographic evaluation, according to the American College of Cardiology 14
The European Society of Cardiology proposes the Integrated Wall Thickness (IWT) echocardiographic score, where values ≥8 can be diagnostic of ATTR cardiac amyloidosis when combined with positive bone scintigraphy and other criteria 14

Clinical Integration and Limitations

The American Heart Association emphasizes that echocardiography cannot distinguish AL (light chain) from ATTR (transthyretin) cardiac amyloidosis, and further testing with monoclonal protein screening and/or nuclear imaging is required for subtype determination 14
The American College of Cardiology recommends proceeding immediately with monoclonal protein screening, NT-proBNP and troponin measurement, and nuclear imaging with bone tracers for ATTR diagnosis when echocardiography shows suggestive findings 14, 15

Echocardiographic Diagnosis of Cardiac Amyloidosis

Introduction to Echocardiographic Findings

Transthoracic echocardiography is the primary diagnostic imaging tool for suspected cardiac amyloidosis, providing multiple "red flag" findings that should prompt further diagnostic workup, according to the American College of Cardiology 16

Structural and Functional Abnormalities

Thickened cardiac valves (both atrioventricular and semilunar) without significant stenosis are a characteristic finding in cardiac amyloidosis, as recommended by the American College of Cardiology 16
Pericardial effusion may be present in some cases of cardiac amyloidosis, as noted by the American College of Cardiology 16
Reduced ventricular longitudinal strain with characteristic apical sparing pattern is a critical finding in cardiac amyloidosis, according to the American College of Cardiology 16

Advanced Echocardiographic Techniques and Diagnostic Clues

Longitudinal strain analysis reveals the characteristic apical sparing pattern, where basal and mid-ventricular segments show reduced strain while apical segments are relatively preserved, as recommended by the American College of Cardiology 16
The combination of low QRS voltage on ECG (<0.5 mV in limb leads) with increased LV wall thickness on echocardiography (>12 mm) is highly specific for cardiac amyloidosis, according to the American College of Cardiology 16

Clinical Integration and Next Steps

When echocardiography shows suggestive findings, nuclear imaging with bone tracers (99mTc-PYP/DPD/HMDP) for ATTR diagnosis is recommended if monoclonal protein screening is negative, as suggested by the European Society of Cardiology 17, 18, 19
Cardiac MRI is recommended when echo is suggestive but equivocal, particularly for tissue characterization, according to the European Society of Cardiology 19